

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | phospholipid efflux (GO:0033700) | 9.95831683 |
| 2 | regulation of triglyceride catabolic process (GO:0010896) | 9.55105197 |
| 3 | reverse cholesterol transport (GO:0043691) | 8.56893891 |
| 4 | plasma lipoprotein particle assembly (GO:0034377) | 8.22118177 |
| 5 | very-low-density lipoprotein particle assembly (GO:0034379) | 7.47557982 |
| 6 | regulation of cholesterol esterification (GO:0010872) | 7.34217503 |
| 7 | protein-lipid complex assembly (GO:0065005) | 7.20789442 |
| 8 | cholesterol efflux (GO:0033344) | 7.10388269 |
| 9 | protein-lipid complex remodeling (GO:0034368) | 6.15916030 |
| 10 | macromolecular complex remodeling (GO:0034367) | 6.15916030 |
| 11 | plasma lipoprotein particle remodeling (GO:0034369) | 6.15916030 |
| 12 | negative regulation of lipase activity (GO:0060192) | 6.10433422 |
| 13 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 5.98938044 |
| 14 | polyol transport (GO:0015791) | 5.28703865 |
| 15 | negative regulation of cholesterol transport (GO:0032375) | 5.22824880 |
| 16 | negative regulation of sterol transport (GO:0032372) | 5.22824880 |
| 17 | regulation of lipoprotein metabolic process (GO:0050746) | 5.10880276 |
| 18 | lipoprotein transport (GO:0042953) | 5.08424252 |
| 19 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.01540691 |
| 20 | cellular response to zinc ion (GO:0071294) | 4.66541304 |
| 21 | plasma lipoprotein particle organization (GO:0071827) | 4.57537940 |
| 22 | plasma lipoprotein particle clearance (GO:0034381) | 4.56409773 |
| 23 | acrosome reaction (GO:0007340) | 4.53810176 |
| 24 | response to pheromone (GO:0019236) | 4.46329283 |
| 25 | transepithelial transport (GO:0070633) | 4.43622086 |
| 26 | ovulation from ovarian follicle (GO:0001542) | 4.32968186 |
| 27 | protein-lipid complex subunit organization (GO:0071825) | 4.24363493 |
| 28 | triglyceride homeostasis (GO:0070328) | 4.18924117 |
| 29 | acylglycerol homeostasis (GO:0055090) | 4.18924117 |
| 30 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.05857857 |
| 31 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.05857857 |
| 32 | regulation of triglyceride metabolic process (GO:0090207) | 4.02782113 |
| 33 | regulation of lipoprotein particle clearance (GO:0010984) | 3.90418244 |
| 34 | positive regulation of steroid metabolic process (GO:0045940) | 3.78682453 |
| 35 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.72121711 |
| 36 | negative regulation of lipid catabolic process (GO:0050995) | 3.68142914 |
| 37 | cholesterol transport (GO:0030301) | 3.67562906 |
| 38 | sterol transport (GO:0015918) | 3.67562906 |
| 39 | protein carboxylation (GO:0018214) | 3.66177912 |
| 40 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.66177912 |
| 41 | chemosensory behavior (GO:0007635) | 3.60154241 |
| 42 | regulation of fatty acid biosynthetic process (GO:0042304) | 3.49785488 |
| 43 | negative regulation of gluconeogenesis (GO:0045721) | 3.46863713 |
| 44 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.44733321 |
| 45 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.44733321 |
| 46 | multicellular organism reproduction (GO:0032504) | 3.35886343 |
| 47 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.31309410 |
| 48 | serotonin receptor signaling pathway (GO:0007210) | 3.27340894 |
| 49 | removal of superoxide radicals (GO:0019430) | 3.24716085 |
| 50 | cellular response to superoxide (GO:0071451) | 3.24716085 |
| 51 | cellular response to oxygen radical (GO:0071450) | 3.24716085 |
| 52 | regulation of sterol transport (GO:0032371) | 3.23945641 |
| 53 | regulation of cholesterol transport (GO:0032374) | 3.23945641 |
| 54 | regulation of lipoprotein lipase activity (GO:0051004) | 3.23825410 |
| 55 | response to hydroperoxide (GO:0033194) | 3.20908312 |
| 56 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 3.19550184 |
| 57 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.18876260 |
| 58 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.15942862 |
| 59 | lipoprotein metabolic process (GO:0042157) | 3.15699863 |
| 60 | acylglycerol catabolic process (GO:0046464) | 3.14799283 |
| 61 | neutral lipid catabolic process (GO:0046461) | 3.14799283 |
| 62 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.14182005 |
| 63 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.13298594 |
| 64 | synapsis (GO:0007129) | 3.12659628 |
| 65 | sphingoid metabolic process (GO:0046519) | 3.10968499 |
| 66 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 3.08568004 |
| 67 | sperm capacitation (GO:0048240) | 3.07142000 |
| 68 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.07117847 |
| 69 | cholesterol homeostasis (GO:0042632) | 3.05403953 |
| 70 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.04425902 |
| 71 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.04361758 |
| 72 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.03605453 |
| 73 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.03073461 |
| 74 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.99951356 |
| 75 | glial cell proliferation (GO:0014009) | 2.98041936 |
| 76 | sterol homeostasis (GO:0055092) | 2.96940560 |
| 77 | triglyceride catabolic process (GO:0019433) | 2.91134272 |
| 78 | negative regulation of metanephros development (GO:0072217) | 2.85753924 |
| 79 | response to phenylpropanoid (GO:0080184) | 2.84178156 |
| 80 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.83397154 |
| 81 | mannosylation (GO:0097502) | 2.82739715 |
| 82 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.79770554 |
| 83 | phototransduction, visible light (GO:0007603) | 2.79715225 |
| 84 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.79557226 |
| 85 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.77923157 |
| 86 | progesterone metabolic process (GO:0042448) | 2.75272831 |
| 87 | phagocytosis, recognition (GO:0006910) | 2.75159861 |
| 88 | sphingosine metabolic process (GO:0006670) | 2.75052571 |
| 89 | positive regulation of vesicle fusion (GO:0031340) | 2.74480192 |
| 90 | piRNA metabolic process (GO:0034587) | 2.71651443 |
| 91 | centriole replication (GO:0007099) | 2.69081531 |
| 92 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 2.67665058 |
| 93 | positive regulation of lipid catabolic process (GO:0050996) | 2.67559527 |
| 94 | one-carbon compound transport (GO:0019755) | 2.64246368 |
| 95 | intra-S DNA damage checkpoint (GO:0031573) | 2.61519141 |
| 96 | response to superoxide (GO:0000303) | 2.61307274 |
| 97 | response to oxygen radical (GO:0000305) | 2.60268017 |
| 98 | peptide biosynthetic process (GO:0043043) | 2.59573302 |
| 99 | detection of visible light (GO:0009584) | 2.59139387 |
| 100 | high-density lipoprotein particle remodeling (GO:0034375) | 10.2070942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.52092191 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 3.39143820 |
| 3 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.94063003 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.71910356 |
| 5 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.56217215 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.48222178 |
| 7 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.37314597 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.26925454 |
| 9 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.24779677 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.19155644 |
| 11 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.12277558 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.11366659 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.10302728 |
| 14 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.02945052 |
| 15 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 2.02611284 |
| 16 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 2.02611284 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.99525018 |
| 18 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.86356720 |
| 19 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.85887899 |
| 20 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.85887899 |
| 21 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.85441422 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.84226799 |
| 23 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.83643765 |
| 24 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.83195568 |
| 25 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.78779159 |
| 26 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.77211441 |
| 27 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.70214934 |
| 28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.68532875 |
| 29 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.67722050 |
| 30 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.61846400 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.60150815 |
| 32 | FUS_26573619_Chip-Seq_HEK293_Human | 1.57721727 |
| 33 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.56984709 |
| 34 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.55934659 |
| 35 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.49894608 |
| 36 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.49812773 |
| 37 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.49413060 |
| 38 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.46909350 |
| 39 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.44587536 |
| 40 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.44060665 |
| 41 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.40479469 |
| 42 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.38773924 |
| 43 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.38542593 |
| 44 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.37954603 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.37750428 |
| 46 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.36709142 |
| 47 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.35353317 |
| 48 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.35110480 |
| 49 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.32801233 |
| 50 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.32171540 |
| 51 | AR_20517297_ChIP-Seq_VCAP_Human | 1.28171357 |
| 52 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.27688707 |
| 53 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.26724294 |
| 54 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.26140292 |
| 55 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.23874488 |
| 56 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.23874488 |
| 57 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.22903081 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22737990 |
| 59 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.20393194 |
| 60 | NCOR_22424771_ChIP-Seq_293T_Human | 1.20192497 |
| 61 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.19986081 |
| 62 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.19757991 |
| 63 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.17583293 |
| 64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16959556 |
| 65 | GATA3_26560356_Chip-Seq_TH1_Human | 1.16756867 |
| 66 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.16523013 |
| 67 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.16129554 |
| 68 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16094438 |
| 69 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.14394451 |
| 70 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.13079764 |
| 71 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12395144 |
| 72 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.10847697 |
| 73 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.10773197 |
| 74 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.10521056 |
| 75 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.10231894 |
| 76 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.10151026 |
| 77 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08914604 |
| 78 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.08879353 |
| 79 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.08025094 |
| 80 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06432845 |
| 81 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.06147510 |
| 82 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.05873476 |
| 83 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.03206581 |
| 84 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.02753186 |
| 85 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.01388309 |
| 86 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00947088 |
| 87 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00869737 |
| 88 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.00166299 |
| 89 | CBP_21632823_ChIP-Seq_H3396_Human | 0.99866285 |
| 90 | EWS_26573619_Chip-Seq_HEK293_Human | 0.98201633 |
| 91 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97555437 |
| 92 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.97262613 |
| 93 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.97191787 |
| 94 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96686625 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96605545 |
| 96 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.94123044 |
| 97 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94044912 |
| 98 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93960784 |
| 99 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93627673 |
| 100 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93350752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.42582056 |
| 2 | MP0006054_spinal_hemorrhage | 4.04227730 |
| 3 | MP0001873_stomach_inflammation | 3.14401024 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.10146005 |
| 5 | MP0010329_abnormal_lipoprotein_level | 2.41199884 |
| 6 | MP0004147_increased_porphyrin_level | 2.33650426 |
| 7 | MP0003186_abnormal_redox_activity | 2.32662249 |
| 8 | MP0000372_irregular_coat_pigmentation | 2.29957357 |
| 9 | MP0004270_analgesia | 2.28266237 |
| 10 | MP0003878_abnormal_ear_physiology | 2.25012092 |
| 11 | MP0005377_hearing/vestibular/ear_phenot | 2.25012092 |
| 12 | MP0002876_abnormal_thyroid_physiology | 2.24405540 |
| 13 | MP0005551_abnormal_eye_electrophysiolog | 2.12524726 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.10107911 |
| 15 | MP0003567_abnormal_fetal_cardiomyocyte | 2.07917711 |
| 16 | MP0002163_abnormal_gland_morphology | 2.03224452 |
| 17 | MP0001958_emphysema | 2.01925618 |
| 18 | MP0009840_abnormal_foam_cell | 10.6099485 |
| 19 | MP0006072_abnormal_retinal_apoptosis | 1.91270099 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 1.79851066 |
| 21 | MP0004142_abnormal_muscle_tone | 1.65755182 |
| 22 | MP0005379_endocrine/exocrine_gland_phen | 1.59060238 |
| 23 | MP0004264_abnormal_extraembryonic_tissu | 1.54561910 |
| 24 | MP0010307_abnormal_tumor_latency | 1.43319387 |
| 25 | MP0008058_abnormal_DNA_repair | 1.38253154 |
| 26 | MP0005367_renal/urinary_system_phenotyp | 1.28693315 |
| 27 | MP0000516_abnormal_urinary_system | 1.28693315 |
| 28 | MP0004145_abnormal_muscle_electrophysio | 1.25407466 |
| 29 | MP0001666_abnormal_nutrient_absorption | 1.22557915 |
| 30 | MP0003183_abnormal_peptide_metabolism | 1.21327357 |
| 31 | MP0005410_abnormal_fertilization | 1.21181856 |
| 32 | MP0001986_abnormal_taste_sensitivity | 1.20037041 |
| 33 | MP0002822_catalepsy | 1.13418341 |
| 34 | MP0005253_abnormal_eye_physiology | 1.13226720 |
| 35 | MP0005365_abnormal_bile_salt | 1.10841793 |
| 36 | MP0004782_abnormal_surfactant_physiolog | 1.10196051 |
| 37 | MP0005332_abnormal_amino_acid | 1.08727288 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.06055429 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 1.05544745 |
| 40 | MP0000003_abnormal_adipose_tissue | 1.04865134 |
| 41 | MP0002254_reproductive_system_inflammat | 1.04767911 |
| 42 | MP0008057_abnormal_DNA_replication | 1.01900443 |
| 43 | MP0005389_reproductive_system_phenotype | 0.99826771 |
| 44 | MP0006292_abnormal_olfactory_placode | 0.97776947 |
| 45 | MP0003718_maternal_effect | 0.95645616 |
| 46 | MP0002160_abnormal_reproductive_system | 0.95389163 |
| 47 | MP0001919_abnormal_reproductive_system | 0.92931828 |
| 48 | MP0010155_abnormal_intestine_physiology | 0.92716414 |
| 49 | MP0001324_abnormal_eye_pigmentation | 0.91356153 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 0.90399747 |
| 51 | MP0001790_abnormal_immune_system | 0.87726296 |
| 52 | MP0005387_immune_system_phenotype | 0.87726296 |
| 53 | MP0000427_abnormal_hair_cycle | 0.87501363 |
| 54 | MP0005171_absent_coat_pigmentation | 0.87090846 |
| 55 | MP0002557_abnormal_social/conspecific_i | 0.83247346 |
| 56 | MP0008877_abnormal_DNA_methylation | 0.82541297 |
| 57 | MP0000681_abnormal_thyroid_gland | 0.80405014 |
| 58 | MP0010352_gastrointestinal_tract_polyps | 0.79140148 |
| 59 | MP0001764_abnormal_homeostasis | 0.79100562 |
| 60 | MP0001293_anophthalmia | 0.78485720 |
| 61 | MP0000653_abnormal_sex_gland | 0.78142505 |
| 62 | MP0002166_altered_tumor_susceptibility | 0.78021181 |
| 63 | MP0001119_abnormal_female_reproductive | 0.78010556 |
| 64 | MP0010094_abnormal_chromosome_stability | 0.77198508 |
| 65 | MP0001485_abnormal_pinna_reflex | 0.76505762 |
| 66 | MP0003943_abnormal_hepatobiliary_system | 0.75589712 |
| 67 | MP0005220_abnormal_exocrine_pancreas | 0.75144003 |
| 68 | MP0006036_abnormal_mitochondrial_physio | 0.74921174 |
| 69 | MP0002295_abnormal_pulmonary_circulatio | 0.74162482 |
| 70 | MP0002118_abnormal_lipid_homeostasis | 0.73553312 |
| 71 | MP0005075_abnormal_melanosome_morpholog | 0.73220228 |
| 72 | MP0005646_abnormal_pituitary_gland | 0.72781401 |
| 73 | MP0002210_abnormal_sex_determination | 0.68274301 |
| 74 | MP0003195_calcinosis | 0.67046895 |
| 75 | MP0001800_abnormal_humoral_immune | 0.67043070 |
| 76 | MP0000639_abnormal_adrenal_gland | 0.65929227 |
| 77 | MP0009697_abnormal_copulation | 0.65168255 |
| 78 | MP0001145_abnormal_male_reproductive | 0.63354095 |
| 79 | MP0005397_hematopoietic_system_phenotyp | 0.63163931 |
| 80 | MP0001545_abnormal_hematopoietic_system | 0.63163931 |
| 81 | MP0002733_abnormal_thermal_nociception | 0.59526356 |
| 82 | MP0009642_abnormal_blood_homeostasis | 0.59241373 |
| 83 | MP0003699_abnormal_female_reproductive | 0.58582884 |
| 84 | MP0003011_delayed_dark_adaptation | 0.58007449 |
| 85 | MP0004043_abnormal_pH_regulation | 0.56299810 |
| 86 | MP0002090_abnormal_vision | 0.55254157 |
| 87 | MP0001929_abnormal_gametogenesis | 0.55254000 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 0.55235704 |
| 89 | MP0005535_abnormal_body_temperature | 0.55064408 |
| 90 | MP0003698_abnormal_male_reproductive | 0.54058434 |
| 91 | MP0002405_respiratory_system_inflammati | 0.53448204 |
| 92 | MP0002693_abnormal_pancreas_physiology | 0.52998364 |
| 93 | MP0002148_abnormal_hypersensitivity_rea | 0.51396007 |
| 94 | MP0001502_abnormal_circadian_rhythm | 0.50747567 |
| 95 | MP0002734_abnormal_mechanical_nocicepti | 0.50598325 |
| 96 | MP0000371_diluted_coat_color | 0.50482241 |
| 97 | MP0003632_abnormal_nervous_system | 0.50444052 |
| 98 | MP0005671_abnormal_response_to | 0.50369815 |
| 99 | MP0009333_abnormal_splenocyte_physiolog | 0.49094482 |
| 100 | MP0002229_neurodegeneration | 0.48743698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 7.68824005 |
| 2 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 7.26100005 |
| 3 | Abnormality of alanine metabolism (HP:0010916) | 7.26100005 |
| 4 | Hyperalaninemia (HP:0003348) | 7.26100005 |
| 5 | Hyperlipoproteinemia (HP:0010980) | 5.10573802 |
| 6 | Microretrognathia (HP:0000308) | 4.28740527 |
| 7 | Decreased central vision (HP:0007663) | 3.96553383 |
| 8 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.96111730 |
| 9 | Hypolipoproteinemia (HP:0010981) | 3.91815594 |
| 10 | Diastasis recti (HP:0001540) | 3.76944436 |
| 11 | Abnormality of serum amino acid levels (HP:0003112) | 3.75890508 |
| 12 | Malnutrition (HP:0004395) | 3.72952211 |
| 13 | Type 2 muscle fiber atrophy (HP:0003554) | 3.59078127 |
| 14 | Dyschromatopsia (HP:0007641) | 3.58043864 |
| 15 | Pigmentary retinal degeneration (HP:0001146) | 3.56920362 |
| 16 | Cone-rod dystrophy (HP:0000548) | 3.37064329 |
| 17 | Abnormality of macular pigmentation (HP:0008002) | 3.34033557 |
| 18 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.29380205 |
| 19 | Vacuolated lymphocytes (HP:0001922) | 3.21232056 |
| 20 | Nausea (HP:0002018) | 3.05703016 |
| 21 | Hypomagnesemia (HP:0002917) | 2.97705018 |
| 22 | Muscle fiber atrophy (HP:0100295) | 2.92422271 |
| 23 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.86285171 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.83022054 |
| 25 | Cutaneous melanoma (HP:0012056) | 2.82017851 |
| 26 | Hyperglycinemia (HP:0002154) | 2.79879075 |
| 27 | Abolished electroretinogram (ERG) (HP:0000550) | 2.71634500 |
| 28 | Truncal obesity (HP:0001956) | 2.68184571 |
| 29 | Macular degeneration (HP:0000608) | 2.62959352 |
| 30 | Proximal tubulopathy (HP:0000114) | 2.62444541 |
| 31 | J-shaped sella turcica (HP:0002680) | 2.55759778 |
| 32 | Renal cortical cysts (HP:0000803) | 2.54794104 |
| 33 | Increased corneal curvature (HP:0100692) | 2.46667449 |
| 34 | Keratoconus (HP:0000563) | 2.46667449 |
| 35 | Broad alveolar ridges (HP:0000187) | 2.45868667 |
| 36 | Tetany (HP:0001281) | 2.42210294 |
| 37 | Congenital sensorineural hearing impairment (HP:0008527) | 2.38755888 |
| 38 | Joint hemorrhage (HP:0005261) | 2.38636713 |
| 39 | Abnormality of magnesium homeostasis (HP:0004921) | 2.38503741 |
| 40 | Aplastic anemia (HP:0001915) | 2.36973197 |
| 41 | Hypoplasia of the uterus (HP:0000013) | 2.34606748 |
| 42 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.34183279 |
| 43 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.34183279 |
| 44 | Abnormality of midbrain morphology (HP:0002418) | 2.33639066 |
| 45 | Molar tooth sign on MRI (HP:0002419) | 2.33639066 |
| 46 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.31688670 |
| 47 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.31688670 |
| 48 | Abnormality of glycolipid metabolism (HP:0010969) | 2.31688670 |
| 49 | Pendular nystagmus (HP:0012043) | 2.22034545 |
| 50 | Central scotoma (HP:0000603) | 2.17757236 |
| 51 | Prolonged partial thromboplastin time (HP:0003645) | 2.15790333 |
| 52 | Abnormality of macrophages (HP:0004311) | 2.15764366 |
| 53 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.11277005 |
| 54 | Genital tract atresia (HP:0001827) | 2.09925042 |
| 55 | Hypoplastic pelvis (HP:0008839) | 2.09509467 |
| 56 | Rhinitis (HP:0012384) | 2.04384832 |
| 57 | Facial diplegia (HP:0001349) | 2.02884438 |
| 58 | Vaginal atresia (HP:0000148) | 2.02190656 |
| 59 | Congenital stationary night blindness (HP:0007642) | 2.01286839 |
| 60 | Congenital primary aphakia (HP:0007707) | 1.98911948 |
| 61 | Severe visual impairment (HP:0001141) | 1.96667177 |
| 62 | Acute lymphatic leukemia (HP:0006721) | 1.94829190 |
| 63 | Acanthocytosis (HP:0001927) | 1.94056630 |
| 64 | Abnormality of vitamin B metabolism (HP:0004340) | 1.90960235 |
| 65 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.88316056 |
| 66 | Gait imbalance (HP:0002141) | 1.87854838 |
| 67 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.86639077 |
| 68 | Dysostosis multiplex (HP:0000943) | 1.85849105 |
| 69 | Delayed CNS myelination (HP:0002188) | 1.84972933 |
| 70 | Medial flaring of the eyebrow (HP:0010747) | 1.84669665 |
| 71 | Abnormality of the renal cortex (HP:0011035) | 1.84417185 |
| 72 | Inability to walk (HP:0002540) | 1.83041953 |
| 73 | Prolonged neonatal jaundice (HP:0006579) | 1.80820374 |
| 74 | Hypoplasia of the iris (HP:0007676) | 1.77831480 |
| 75 | Metabolic acidosis (HP:0001942) | 1.75697112 |
| 76 | Abnormality of the prostate (HP:0008775) | 1.75319439 |
| 77 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.73482580 |
| 78 | Nonprogressive disorder (HP:0003680) | 1.73277632 |
| 79 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.73114678 |
| 80 | Dysdiadochokinesis (HP:0002075) | 1.69224899 |
| 81 | Inappropriate behavior (HP:0000719) | 1.68640820 |
| 82 | Abnormality of glycine metabolism (HP:0010895) | 1.68426345 |
| 83 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.68426345 |
| 84 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.68322689 |
| 85 | Panhypogammaglobulinemia (HP:0003139) | 1.68045936 |
| 86 | Chronic sinusitis (HP:0011109) | 1.67965731 |
| 87 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.67963824 |
| 88 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.67553616 |
| 89 | Hypochromic microcytic anemia (HP:0004840) | 1.65194883 |
| 90 | Nephrogenic diabetes insipidus (HP:0009806) | 1.64766617 |
| 91 | Hyperammonemia (HP:0001987) | 1.64667486 |
| 92 | 3-Methylglutaconic aciduria (HP:0003535) | 1.64637396 |
| 93 | Methylmalonic acidemia (HP:0002912) | 1.64360843 |
| 94 | Attenuation of retinal blood vessels (HP:0007843) | 1.63692188 |
| 95 | Progressive inability to walk (HP:0002505) | 1.62793516 |
| 96 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.61796340 |
| 97 | Stenosis of the external auditory canal (HP:0000402) | 1.60816690 |
| 98 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.60438559 |
| 99 | Ectropion (HP:0000656) | 1.60063807 |
| 100 | Flared iliac wings (HP:0002869) | 1.58803678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CG | 7.82496681 |
| 2 | MUSK | 6.84626821 |
| 3 | MAP4K2 | 3.95962107 |
| 4 | TNIK | 3.68497683 |
| 5 | BCKDK | 2.65855697 |
| 6 | MAP3K12 | 2.63922326 |
| 7 | TXK | 2.49037166 |
| 8 | NLK | 2.39057268 |
| 9 | TESK2 | 2.31766002 |
| 10 | FLT3 | 2.11096195 |
| 11 | PDK2 | 2.05252784 |
| 12 | FRK | 1.96744285 |
| 13 | TAOK3 | 1.95980351 |
| 14 | WNK3 | 1.95914662 |
| 15 | ACVR1B | 1.68967426 |
| 16 | MAP3K6 | 1.61158721 |
| 17 | MAP3K4 | 1.57518292 |
| 18 | CSF1R | 1.50264810 |
| 19 | MAP2K3 | 1.48793774 |
| 20 | ERBB3 | 1.44834423 |
| 21 | RPS6KA4 | 1.27388371 |
| 22 | KIT | 1.19645251 |
| 23 | MAP2K6 | 1.16395994 |
| 24 | MAP2K4 | 1.14495101 |
| 25 | MYLK | 1.09562295 |
| 26 | BRSK2 | 1.07057961 |
| 27 | STK38L | 1.05514105 |
| 28 | YES1 | 1.02855268 |
| 29 | BMPR1B | 1.02682610 |
| 30 | PRKCE | 0.93773964 |
| 31 | FGFR2 | 0.92431247 |
| 32 | TRIM28 | 0.88537823 |
| 33 | TNK2 | 0.86975858 |
| 34 | GRK1 | 0.85296157 |
| 35 | PTK2B | 0.83622215 |
| 36 | PIK3CA | 0.82856449 |
| 37 | WEE1 | 0.82052419 |
| 38 | MATK | 0.77300922 |
| 39 | SYK | 0.75208934 |
| 40 | TRPM7 | 0.74905226 |
| 41 | PAK3 | 0.73633477 |
| 42 | NUAK1 | 0.71741519 |
| 43 | ADRBK2 | 0.66931866 |
| 44 | PASK | 0.66831184 |
| 45 | EIF2AK1 | 0.61270607 |
| 46 | DYRK3 | 0.58973245 |
| 47 | RET | 0.56656170 |
| 48 | NTRK3 | 0.56093026 |
| 49 | MAP2K7 | 0.55658162 |
| 50 | MKNK2 | 0.54054121 |
| 51 | ZAP70 | 0.49382377 |
| 52 | PBK | 0.49349918 |
| 53 | MKNK1 | 0.47356707 |
| 54 | PRKG2 | 0.45377745 |
| 55 | NME1 | 0.44325632 |
| 56 | RPS6KB2 | 0.44006166 |
| 57 | EIF2AK3 | 0.43997795 |
| 58 | TLK1 | 0.43977417 |
| 59 | SGK2 | 0.42194504 |
| 60 | ITK | 0.40564080 |
| 61 | ADRBK1 | 0.40540283 |
| 62 | PRKACB | 0.39158793 |
| 63 | TGFBR1 | 0.38717714 |
| 64 | NEK6 | 0.36652507 |
| 65 | TEC | 0.36035009 |
| 66 | CSK | 0.34804735 |
| 67 | PRKCG | 0.34280875 |
| 68 | CDK8 | 0.33450322 |
| 69 | PINK1 | 0.32414604 |
| 70 | FGFR1 | 0.31577785 |
| 71 | CDK4 | 0.31444432 |
| 72 | ABL2 | 0.31125827 |
| 73 | CSNK2A1 | 0.27388586 |
| 74 | STK3 | 0.27108639 |
| 75 | CDK6 | 0.26627384 |
| 76 | CSNK1G2 | 0.24929820 |
| 77 | HIPK2 | 0.24525241 |
| 78 | STK11 | 0.24210736 |
| 79 | PRKAA2 | 0.24072530 |
| 80 | PDK1 | 0.23448107 |
| 81 | PKN1 | 0.21627399 |
| 82 | STK24 | 0.21220569 |
| 83 | SGK494 | 0.20194994 |
| 84 | SGK223 | 0.20194994 |
| 85 | PRKCA | 0.19999493 |
| 86 | PRKACG | 0.19405028 |
| 87 | CSNK2A2 | 0.18724198 |
| 88 | RPS6KB1 | 0.17642748 |
| 89 | STK39 | 0.17339706 |
| 90 | IGF1R | 0.16679895 |
| 91 | HCK | 0.16350425 |
| 92 | MINK1 | 0.15836635 |
| 93 | ROCK1 | 0.15229532 |
| 94 | MAP3K5 | 0.15182864 |
| 95 | AURKB | 0.15056481 |
| 96 | MAP3K7 | 0.14522851 |
| 97 | ROCK2 | 0.12674016 |
| 98 | CAMKK2 | 0.12369107 |
| 99 | RIPK4 | 0.12251828 |
| 100 | DAPK3 | 0.12231161 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 5.48244959 |
| 2 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 3.84824049 |
| 3 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.29711434 |
| 4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.95685560 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.94535851 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.79974998 |
| 7 | Galactose metabolism_Homo sapiens_hsa00052 | 2.57781803 |
| 8 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 2.44053606 |
| 9 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.30294484 |
| 10 | Mineral absorption_Homo sapiens_hsa04978 | 2.06316106 |
| 11 | Protein export_Homo sapiens_hsa03060 | 1.93747428 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.70301983 |
| 13 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.68234620 |
| 14 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.65268137 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.64382056 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.52350803 |
| 17 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.52214111 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.50969201 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.45467084 |
| 20 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.44339150 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.40593393 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.39062264 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.37872883 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.34877726 |
| 25 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.31744120 |
| 26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.30166305 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.27773409 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.27752977 |
| 29 | Phototransduction_Homo sapiens_hsa04744 | 1.25085538 |
| 30 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.23626886 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.21288747 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.18514107 |
| 33 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.15293391 |
| 34 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.13497918 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.09393264 |
| 36 | Purine metabolism_Homo sapiens_hsa00230 | 1.06441041 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.03714191 |
| 38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.03449719 |
| 39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.00882531 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.98452995 |
| 41 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.96956976 |
| 42 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.96128422 |
| 43 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.95779743 |
| 44 | RNA degradation_Homo sapiens_hsa03018 | 0.91887093 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.90751063 |
| 46 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90593464 |
| 47 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.90450491 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.89069894 |
| 49 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.85266508 |
| 50 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.85181630 |
| 51 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.85012466 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 0.84968301 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.83406840 |
| 54 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.83158440 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 0.81242782 |
| 56 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.80949962 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.80738230 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76403627 |
| 59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.75119963 |
| 60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.73265204 |
| 61 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.72380172 |
| 62 | Homologous recombination_Homo sapiens_hsa03440 | 0.71731134 |
| 63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71028629 |
| 64 | RNA transport_Homo sapiens_hsa03013 | 0.70021006 |
| 65 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.69598520 |
| 66 | Retinol metabolism_Homo sapiens_hsa00830 | 0.69097940 |
| 67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.68958800 |
| 68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.66668956 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.65541548 |
| 70 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.61250858 |
| 71 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.60972607 |
| 72 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.59099887 |
| 73 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.57864016 |
| 74 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.57674538 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56711704 |
| 76 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55601448 |
| 77 | Nicotine addiction_Homo sapiens_hsa05033 | 0.55542533 |
| 78 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.54012770 |
| 79 | Base excision repair_Homo sapiens_hsa03410 | 0.53929813 |
| 80 | RNA polymerase_Homo sapiens_hsa03020 | 0.52903222 |
| 81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.51253685 |
| 82 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50040798 |
| 83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49922834 |
| 84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.47178612 |
| 85 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42537188 |
| 86 | Salivary secretion_Homo sapiens_hsa04970 | 0.41751206 |
| 87 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41376600 |
| 88 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.39999606 |
| 89 | Morphine addiction_Homo sapiens_hsa05032 | 0.39087462 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.37934899 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.34255895 |
| 92 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.30244256 |
| 93 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.29818911 |
| 94 | Histidine metabolism_Homo sapiens_hsa00340 | 0.29497632 |
| 95 | Olfactory transduction_Homo sapiens_hsa04740 | 0.29298934 |
| 96 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.27279679 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26473550 |
| 98 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.25232240 |
| 99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23608173 |
| 100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.23268525 |

